1. Introduction {#sec0001}
===============

On March 11th, 2020, the novel coronavirus disease (COVID-19) was declared a global pandemic, instantiating physical distancing and quarantine orders to mitigate its rapid transmission. Past studies have documented the effects of infectious outbreaks and subsequent quarantine orders, on both posttraumatic stress disturbance ([@bib0007]) and psychological stress ([@bib0004]; [@bib0012]) experienced in the general population. In addition to psychosocial stressors, such as financial strain and isolation ([@bib0021]), COVID-19 may also increase stress due to fear of infection to oneself or loved ones ([@bib0010]). Altogether, the uncontrollable and unpredictable nature of COVID-19 has likely led to extraordinary stress in the general population.

Emerging literature indicates stress reactions are occurring in response to COVID-19 (e.g., [@bib0024]), however, prevalence estimates vary widely. The prevalence of posttraumatic and general stress disturbance may be attenuated or amplified by demographic (e.g., age, sex) or methodological variables (e.g., publication status). In order to guide policy-decisions regarding where to allocate psychological resource and to determine who may be in most need of services, meta-analytic estimates of posttraumatic and psychological stress due to COVID-19 are needed. The purpose of this rapid review and meta-analysis was to attain more precise estimates of general and posttraumatic stress symptoms experienced in population-based samples during COVID-19. We examine posttraumatic and general stress symptoms separately to distinguish symptoms specific to traumatic events (e.g., intrusion, avoidance) and experiences of stress (e.g., difficulty relaxing, nervous arousal) non-specific to events. We also examine factors that may explain between-study variation in prevalence estimates.

2. Method {#sec0002}
=========

PRISMA guidelines were followed. Electronic searches developed by a health sciences librarian were conducted in PsycINFO, Cochrane Central Register of Controlled Trials, Embase, and MEDLINE up to May 26th, 2020 (see PROSPERO \[CRD42020184903\]). Unpublished pre-prints were searched for in PsycArXiv. Key search terms included *COVID-19* and *mental health*. Inclusion criteria were: (1) empirical study; (2) written in English; (3) collected during COVID-19; (4) sample ≥ 18 years; and (5) drawn from general population.

This information was extracted from included studies: (1) brief 6-point study quality assessment (available from authors upon request); (2) participant age; (3) % female in sample; (4) geographical region; (5) type of stress measure (posttraumatic or psychological); and (6) prevalence data. Random agreement probabilities of extracted articles (20%) ranged from 0.73--1.00. Discrepancies were resolved among coders.

Random effects meta-analyses were performed in Comprehensive Meta-Analysis Software (CMA, 3.0; [@bib0003]) to obtain pooled prevalence estimates, which give greater weight to studies with larger sample sizes, with associated 95% confidence intervals (CIs). Extreme cases were identified via box plot inspections in SPSS. Between-study heterogeneity was examined with *Q*- and *I^2^-*statistics ([@bib0008]). Categorical and continuous moderators were explored using group and meta-regression analysis, respectively. Publication bias was examined via inspection of funnel plots. Statistical significance was set at *p* \< .05.

3. Results {#sec0003}
==========

In total, 3,405 non-duplicated abstracts were identified, 175 full-text articles were reviewed, and *k* = 14 non-overlapping studies (*N* = 21,744 participants) were identified for inclusion. No extreme cases were found. On average, participants were 29.47 years of age and 54.39% were female. All studies were cross-sectional and used self-reports of stress symptoms. The mean study quality was 3.07/6.0 (range = 2.00 to 4.00; see [Table 1](#tbl0001){ref-type="table"} for full description of study characteristics).Table 1Characteristics of included studies.Table 1[a](#tb1fn1){ref-type="table-fn"}Study[b](#tb1fn2){ref-type="table-fn"}NAge (years)% FemaleCountryType of StressMeasure of StressDate of Data CollectionPublished? (yes/no)Mean Study Quality Score[@bib0001]50228.7555.20NigeriaPTSIESMar 20 -- Apr 19N4[@bib0002]142725.7528.50BangladeshGSDASS-21Apr 29 -- May 7N2[@bib0006]348037.9275.00SpainPTSPCLMar 21 -- Mar 28Y3[@bib0009]312221.4040.50BangladeshGSDASS-21Apr 11 -- Apr 24N3Khan et al. (2020)505--37.23BangladeshPTS, GSIES, DASS-21Apr 9 -- Apr 23N2[@bib0014]285--54.40ChinaPTSPCLJan 20 -- Feb 8Y4[@bib0015]276632.9471.60ItalyGSDASS-21Mar 18 -- Mar 22Y3[@bib0017]355032.1035.10SpainGSDASS-21Mar 28 -- Apr 4N2[@bib0018]97632.9881.10SpainGSDASS-21Mar 11 -- Mar 15Y3[@bib0019]408--43.00United StatesPTSPCLMay 6 -- May 9N2Tan et al. (2020)67330.825.60ChinaGSDASS-21Feb 24Y4[@bib0022]248519.8161.37ChinaPTSPCLFeb 20 -- Feb 27Y4Wang et al. (2020)1304--67.30ChinaPTS, GSIES, DASS-21Jan 31 -- Feb 2Y3[@bib0025]26337.759.70ChinaPTSIESFeb 15 -- Feb 29Y4[^1][^2][^3]

The pooled prevalence of posttraumatic stress symptoms (*k* = 8) was 23.88% (95% CI: 14.01, 33.76). Significant heterogeneity was identified (*Q* = 118,330.05; *I^2^* = 99.99). Moderators were explored (see Supplementary Table 1) and unpublished studies had significantly higher prevalence estimates (*k* = 3; prevalence = 34.71%; CI: 23.25, 46.19) compared to published studies (*k* = 5; prevalence = 17.38; CI: 6.02, 28.75). Age and sex were not significant moderators.

The pooled prevalence of psychological stress (*k* = 8) was 24.84% (95% CI: 11.75, 37.92). Heterogeneity was significant (*Q* = 265,346.12; *I^2^* = 99.997). Moderators were explored (see Supplementary Table 1) and unpublished studies had significantly higher prevalence estimates (*k* = 4; prevalence = 37.07%; CI: 23.02, 51.11) compared to published studies (*k* = 4; prevalence = 12.61; CI: 1.72, 23.49). Age and sex were not significant moderators. No publication bias or additional moderators were detected in the meta-analyses.

4. Discussion {#sec0004}
=============

Results from the current meta-analysis document high levels of both posttraumatic (26.2%) and psychological (23.1%) stress associated with COVID-19. Although prevalence estimates were lower in peer-reviewed compared to unpublished studies, findings suggested approximately one-in-four adults require mental health services during the ongoing pandemic. While elevations in stress during a global pandemic are to be expected, the long-term implications of these elevations are cause for concern. Specifically, decades of research suggest elevations in overall stress are risk factors or precipitants for the onset of comorbid mental health difficulties such as anxiety, depression, or substance use ([@bib0005]). Exposure to stress over time can also lead to accelerated disease processes and the exacerbation of chronic health conditions, further inflating healthcare costs ([@bib0016]). All told, the broader implications of large increases in stress during COVID-19 at a population level are significant and will require government and policy changes to help reduce stress, such as income supplements, childcare, and development of broadly available prevention and intervention programs that promote stress-reduction strategies such as healthy eating, physical activity, and good sleep habits.

Due to the rapidly evolving nature of COVID-19, the research presented in this rapid review is preliminary in nature and represents a snapshot of stress levels in the months immediately following the pandemic. Most studies to date have reported on cross-sectional data and without representative samples. Publication status moderated effect sizes. Methodological rigor is critical to adequately inform policy, practice, and public dialog. Longitudinal studies are necessary to determine whether these elevations in stress are sustained, reduced, or exacerbated over time ([@bib0020]). Furthermore, studies from different geographic areas with varying severity of exposure to the disease, as well as differences in mitigative strategies (e.g., lockdown, school closures), are needed.
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[^1]: Note. PTS = posttraumatic stress symptoms. GS = general stress symptoms. DASS-21 = Depression, Anxiety, and Stress Scale - 21; IES = Impact of Event Scale; PCL = Posttraumatic Stress Disorder Checklist.

[^2]: All studies were conducted in 2020.

[^3]: Sample size used to calculate prevalence rate.
